Literature DB >> 11348265

Optimal Management of Primary Breast Cancer.

Atilla Soran1, Victor G. Vogel.   

Abstract

The diagnosis and treatment of breast cancer have changed in response to not only new technologies but also cultural and social aspects of the disease. While breast-conserving surgery and adjuvant therapy are the preferred treatments for many breast cancers, neoadjuvant therapy is often used in advanced disease. In this review we examine the treatment options that are influenced by pathologic and clinical factors. Invasive breast cancer is a potentially curable disease if it is regarded and managed by a multidisciplinary approach from the outset.

Entities:  

Year:  1999        PMID: 11348265     DOI: 10.1046/j.1524-4741.1999.00130.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  2 in total

1.  [Suspected contrast medium concentration in dynamic MR-mammography. Post-traumatic fracture of the ribs].

Authors:  A Fink; K Wasser; D Aufderstrasse; H Ludemann; S Delorme
Journal:  Radiologe       Date:  2002-09       Impact factor: 0.635

2.  Evaluation of intraductal delivery of poly(ethylene glycol)-doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)-like lesions in rats.

Authors:  Zichao Gu; Firas Al-Zubaydi; Derek Adler; Shike Li; Steven Johnson; Puja Prasad; Jennifer Holloway; Zoltan Szekely; Susan Love; Dayuan Gao; Patrick J Sinko
Journal:  J Interdiscip Nanomed       Date:  2018-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.